Thermosensitive PLA based nanodispersion for targeting brain tumor via intranasal route.

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Materials Science and Engineering C: Materials for Biological Applications

• Publication date

  2016-06-01

• Fields of study

  Medicine, Materials Science

• Identifiers
  DOI 10.1016/j.msec.2016.03.015PMID 27040235
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Poly lactic acid (PLA) nanoparticles sustain the cytotoxic action of temozolomide in C6 Glioma cells

  2013cited by this paper
• Studies on stabilization mechanism and stealth effect of poloxamer 188 onto PLGA nanoparticles.

  2013cited by this paper
• Low molecular weight protamine-functionalized nanoparticles for drug delivery to the brain after intranasal administration.

  2011cited by this paper
• New strategies to deliver anticancer drugs to brain tumors

  2009cited by this paper
• Dissolution in nasal fluid, retention and anti‐inflammatory activity of fluticasone furoate in human nasal tissue ex vivo

  2009cited by this paper
• UEA I-bearing nanoparticles for brain delivery following intranasal administration.

  2007cited by this paper
• Nasal immunization studies using liposomes loaded with tetanus toxoid and CpG-ODN.

  2006cited by this paper
• Synthesis and drug release behavior of poly (trimethylene carbonate)-poly (ethylene glycol)-poly (trimethylene carbonate) nanoparticles.

  2005cited by this paper
• Nasal mucoadhesive drug delivery: background, applications, trends and future perspectives.

  2005cited by this paper
• Brain delivery of vasoactive intestinal peptide (VIP) following nasal administration to rats.

  2003cited by this paper
• Profiles of methotrexate in blood and CSF following intranasal and intravenous administration to rats.

  2003cited by this paper
• Paclitaxel-loaded PLGA nanoparticles: preparation, physicochemical characterization and in vitro anti-tumoral activity.

  2002cited by this paper
• A Literature Review of Poly(Lactic Acid)

  2001cited by this paper
• Brain potentials and attention after acute and subchronic intranasal administration ofACTH 4-10 and desacetyl-alpha-MSH in humans.

  1999cited by this paper
• Brain Potentials and Attention after Acute and Subchronic Intranasal Administration of ACTH 4–10 and Desacetyl-α-MSH in Humans

  1999cited by this paper
• Central nervous system effects of intranasally administered insulin during euglycemia in men.

  1999cited by this paper
• Preparation of surface-modified albumin nanospheres.

  1997cited by this paper
• Delivery of 125I-NGF to the Brain via the Olfactory Route

  1997cited by this paper
• Brain potential changes after intranasal vs. intravenous administration of vasopressin: evidence for a direct nose-brain pathway for peptide effects in humans.

  1996cited by this paper
• Intrathecal 131I-labeled antitenascin monoclonal antibody 81C6 treatment of patients with leptomeningeal neoplasms or primary brain tumor resection cavities with subarachnoid communication: phase I trial results.

  1996cited by this paper
• A nose-brain pathway for psychotropic peptides: evidence from a brain evoked potential study with cholecystokinin

  1996cited by this paper
• Methylated β-cyclodextrins are able to improve the nasal absorption of salmon calcitonin

  1995cited by this paper
• High-flow microinfusion: tissue penetration and pharmacodynamics.

  1994cited by this paper
• Transport of cephalexin to the cerebrospinal fluid directly from the nasal cavity

  1991cited by this paper
• Grading of astrocytomas: A simple and reproducible method

  1988cited by this paper
• Bioavailability of progesterone enhanced by intranasal spraying

  1981cited by this paper
• The Journal of Clinical Endocrinology & Metabolism Printed in U.S.A. Copyright © 2001 by The Endocrine Society The Melanocortin Melanocyte-Stimulating Hormone/Adrenocorticotropin 4–10 Decreases Body Fat in Humans*

  year unknowncited by this paper

• Intranasal delivery systems for traumatic brain injury: Advancements and perspectives

  2025cites this paper
• Polymeric nanoparticles for efficient nose-to-brain delivery.

  2025cites this paper
• The Nasal–Brain Drug Delivery Route: Mechanisms and Applications to Central Nervous System Diseases

  2025cites this paper
• Microinvasive Deployment and Fate-Determination of Functional, Engineered Nanoparticles in Central Nervous System

  2025cites this paper
• Progress in nasal drug delivery research based on biomaterials

  2025cites this paper
• Exploring intranasal drug delivery via nanocarriers: A promising glioblastoma therapy.

  2024cites this paper
• To see or not to see: In vivo nanocarrier detection methods in the brain and their challenges.

  2024cites this paper
• Nanodispersions for drug delivery applications: a special focus toward cancer therapeutics

  2024cites this paper
• Slightly viscous dispersions of mucoadhesive polymers as vehicles for nasal administration of dopamine and grape seed extract-loaded solid lipid nanoparticles.

  2024cites this paper
• Mucoadhesive chitosan-poly (lactic-co-glycolic acid) nanoparticles for intranasal delivery of quetiapine - Development & characterization in physiologically relevant 3D tissue models.

  2024cites this paper
• Intranasal drug delivery: The interaction between nanoparticles and the nose-to-brain pathway.

  2024cites this paper
• Advances and future perspectives of intranasal drug delivery: A scientometric review.

  2024cites this paper
• Hyaluronic acid-modified and verteporfin-loaded polylactic acid nanogels promote scarless wound healing by accelerating wound re-epithelialization and controlling scar formation

  2023cites this paper
• Nose-to-brain drug delivery for the treatment of glioblastoma multiforme: nanotechnological interventions

  2023cites this paper
• A Comprehensive Review on Nanomedicine: Promising approach for treatment of brain tumor through intranasal administration.

  2022cites this paper
• Nucleic acid-based therapy for brain tumor: Challenges and strategies.

  2022cites this paper
• Intranasal Delivery of Functionalized Polymeric Nanomaterials to the Brain

  2022cites this paper
• Intranasal gene therapy for the treatment of neurological disorders

  2021cites this paper
• NOSE-TO-BRAIN DELIVERY, A ROUTE OF CHOICE FOR TARGETING BRAIN TUMORS

  2021cites this paper
• Polylactic acid-graphene oxide-based materials for loading and sustained release of poorly soluble pesticides.

  2020cites this paper
• Formulation strategies for nose-to-brain delivery of therapeutic molecules

  2020cites this paper
• Pharmacotechnical Development of a Nasal Drug Delivery Composite Nanosystem Intended for Alzheimer’s Disease Treatment

  2020cites this paper
• Nose-to-brain delivery: exploring newer domains for glioblastoma multiforme management

  2020cites this paper
• Recent Advances in Bioplastics: Application and Biodegradation

  2020cites this paper
• Management of epileptic disorders using nanotechnology-based strategies for nose-to-brain drug delivery

  2020cites this paper
• Chondroitin sulfate conjugation facilitates tumor cell internalization of albumin nanoparticles for brain-targeted delivery of temozolomide via CD44 receptor-mediated targeting

  2020cites this paper
• Hyaluronic acid conjugated albumin nanoparticles for efficient receptor mediated brain targeted delivery of temozolomide

  2020cites this paper
• Intranasal delivery of chitosan decorated PLGA core /shell nanoparticles containing flavonoid to reduce oxidative stress in the treatment of Alzheimer's disease

  2020cites this paper
• One- pot development of spray dried cationic proliposomal dry powder insufflation: Optimization, characterization and bio-interactions

  2020cites this paper
• Poly (ɛ-Caprolactone) Nanoparticles with pH-Responsive Behavior Improved the In Vitro Antitumor Activity of Methotrexate

  2019cites this paper
• Nasal Drug Delivery of Anticancer Drugs for the Treatment of Glioblastoma: Preclinical and Clinical Trials

  2019cites this paper
• 1 Nasal Drug Delivery of Anticancer Drugs for the 2 Treatment of Glioblastoma : Preclinical and Clinical 3 Trials 4

  2019cites this paper
• Resorbable polymer fiber reinforced composites in biomedical application

  2019cites this paper
• An Available Strategy for Nasal Brain Transport of Nanocomposite Based on PAMAM Dendrimers via In Situ Gel

  2019cites this paper
• Biocompatibility, biodegradation and biomedical applications of poly(lactic acid)/poly(lactic-co-glycolic acid) micro and nanoparticles

  2019cites this paper
• An update on the role of nanovehicles in nose-to-brain drug delivery.

  2018cites this paper
• Surface-Modified Nanocarriers for Nose-to-Brain Delivery: From Bioadhesion to Targeting

  2018cites this paper
• Selegiline Nanoformulation in Attenuation of Oxidative Stress and Upregulation of Dopamine in the Brain for the Treatment of Parkinson's Disease

  2018cites this paper
• 1 Surface-modified nanocarriers for nose-to-brain 2 delivery : from bioadhesion to targeting 3

  2018cites this paper
• Current development in the formulations of non‐injection administration of paclitaxel

  2018cites this paper
• Local Treatment of Brain Tumors and the Blood-Brain Barrier

  2018cites this paper
• Industrial Applications of Poly(lactic acid)

  2018cites this paper
• Covalent self-assembled nanoparticles with pH-dependent enhanced tumor retention and drug release for improving tumor therapeutic efficiency.

  2017cites this paper
• Poly(lactic acid) Controlled Drug Delivery

  2017cites this paper
• Recent Advances in Preclinical Studies and Potential Applications of Dendrimers as Drug Carriers in the Central Nervous System.

  2017cites this paper
• Targeted and theranostic applications for nanotechnologies in medicine

  2017cites this paper
• Novel biodegradable nanocarriers for enhanced drug delivery.

  2016cites this paper